| Name | Walgreens #10398 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 13911 Nine Eagles Dr, Tampa, Florida 33626 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (813) 814-4285 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.
The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries.
Despite debate about the safety of childhood vaccines among some groups in the public, an overwhelming majority of Americans (82%) support requiring children attending public school to be vaccinated for measles, mumps and rubella (MMR), according to a new Pew Research Center survey.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, today introduced the ACTIS Total Hip System in the US at the 2018 American Academy of Orthopedic Surgeons Annual Meeting in New Orleans, LA. Recently available on a limited basis, this is the first DePuy Synthes hip system designed to be utilized with tissue-sparing approaches such as the minimally invasive Anterior Approach, as well as traditional approaches in Total Hip Replacement surgery.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
› Verified 2 days ago
| NPI Number | 1811184385 |
| Organization Name | WALGREEN CO. |
| Doing Business As | WALGREENS #10398 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 13911 Nine Eagles Dr, Tampa, FL 33626 |
| Phone Number | 813-814-4285 |
News Archive
EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.
The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries.
Despite debate about the safety of childhood vaccines among some groups in the public, an overwhelming majority of Americans (82%) support requiring children attending public school to be vaccinated for measles, mumps and rubella (MMR), according to a new Pew Research Center survey.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, today introduced the ACTIS Total Hip System in the US at the 2018 American Academy of Orthopedic Surgeons Annual Meeting in New Orleans, LA. Recently available on a limited basis, this is the first DePuy Synthes hip system designed to be utilized with tissue-sparing approaches such as the minimally invasive Anterior Approach, as well as traditional approaches in Total Hip Replacement surgery.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
› Verified 2 days ago
News Archive
EnVivo Pharmaceuticals today announced at the Alzheimer's Association 2010 International Conference on Alzheimer's Disease results from its proprietary gamma-secretase modulator pre-clinical study. In a transgenic mouse model, EnVivo's EVP-0015962 reduced amyloid plaque buildup which is believed to be a cause of Alzheimer's disease, reversed behavioral deficits and reduced brain inflammation associated with Alzheimer's disease.
The National Eye Institute (NEI), part of NIH, is participating in the Inaugural Press Conference from the Association for Research in Vision and Ophthalmology Annual Meeting (ARVO 2016), the largest gathering of eye and vision researchers in the world, attracting over 11,000 attendees from more than 75 countries.
Despite debate about the safety of childhood vaccines among some groups in the public, an overwhelming majority of Americans (82%) support requiring children attending public school to be vaccinated for measles, mumps and rubella (MMR), according to a new Pew Research Center survey.
DePuy Synthes, part of the Johnson & Johnson Medical Devices Companies, today introduced the ACTIS Total Hip System in the US at the 2018 American Academy of Orthopedic Surgeons Annual Meeting in New Orleans, LA. Recently available on a limited basis, this is the first DePuy Synthes hip system designed to be utilized with tissue-sparing approaches such as the minimally invasive Anterior Approach, as well as traditional approaches in Total Hip Replacement surgery.
Arena Pharmaceuticals, Inc. and Eisai Inc. announced that the US Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) regarding Arena's New Drug Application (NDA) for lorcaserin. Lorcaserin is intended for weight management, including weight loss and maintenance of weight loss, in patients who are obese
› Verified 2 days ago
6th St. Bridge Mobility Type: Durable Medical Equipment & Medical Supplies Supplier Location: 7818 Depot Ln, Tampa, Florida 33637 Phone: (813) 621-2001 | |
A-ability Medical Equipment Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4010 E Hillsborough Ave, Tampa, Florida 33610 Phone: (813) 620-4475 | |
About You Type: Prosthetic/Orthotic Supplier Location: 3401 Henderson Blvd, Tampa, Florida 33609 Phone: (813) 876-2727 | |
Advance Pharmacy Service Llc Type: Pharmacy Location: 4910 N Armenia Ave, Tampa, Florida 33603 Phone: (813) 350-9999 | |
Advocate Medical Services Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5912 Breckenridge Pkwy, Tampa, Florida 33610 Phone: (813) 280-6547 |